Cognitive Behavioral Therapy (CBT) for Adherence and Depression in Type 1 Diabetes

Completed · Phase 2

Conditions studied: Depression, Type 1 Diabetes

In brief

This study is a pilot behavioral intervention trial, designed to initially examine cognitive behavioral therapy for medical adherence and depression (CBT-AD) in patients with depression and poorly controlled type 1 diabetes.

Key facts

Study ID

NCT01527981

Run by

Massachusetts General Hospital

People needed

9

Starts

2008-03-01

Expected to finish

2010-11-01

Last updated by the study team

2012-02-07

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of type 1 diabetes that is poorly controlled (HbA1C greater than or equal to 8.0%) despite treatment with insulin.
• Diagnosis of major depression and/or dysthymia, or current subclinical symptoms of depression in spite of being treated with antidepressants.
• Age 18-80.
• If on an antidepressant, stable for two months. Oral hypoglycemic medications stable for 2 months, and insulin prescription stable for 2 months (if prescribed).

You may not qualify if…

• Active or untreated major mental illness that would interfere with participation (e.g., untreated psychosis), untreated/unstable bipolar disorder, eating disorder, mental retardation, dementia, or active suicidality.
• Unable or unwilling to provide informed consent.
• History of or current CBT for depression.
• Currently on dialysis.

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.